People on weight loss drugs are not receiving crucial dietary support, leaving them at risk of nutritional deficiencies that could lead to serious health problems, experts have warned.
Around 1.5 million people in the UK are currently using GLP-1 drugs, including popular jabs Mounjaro and Wegovy. But many of those could be “replacing one set of health problems with another” through “preventable nutritional deficiencies,” researchers said.
